We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the trea... Avrobio Inc is a clinical-stage gene therapy company. It is engaged in developing potentially curative ex vivo lentiviral gene therapies to treat rare diseases following a single dose treatment regimen. The company's pipeline includes AVR-RD-04 for the treatment of cystinosis; AVR-RD-02 for the treatment of Gaucher disease type 1; AVR-RD-05 for the treatment of Hunter syndrome; AVR-RD-06 for the treatment of Gaucher disease type 3; and AVR-RD-03 for the treatment of Pompe disease. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 10.73 | 54.0010065425 | 19.87 | 31.31 | 19.6001 | 373457 | 24.53453325 | CS |
| 4 | 11.46 | 59.8746081505 | 19.14 | 31.31 | 17.1804 | 128696 | 23.15652974 | CS |
| 12 | 14.92 | 95.1530612245 | 15.68 | 31.31 | 15.08 | 59238 | 21.28430542 | CS |
| 26 | 13.7 | 81.0650887574 | 16.9 | 31.31 | 15.0001 | 56532 | 20.81323242 | CS |
| 52 | 13.7 | 81.0650887574 | 16.9 | 31.31 | 15.0001 | 56532 | 20.81323242 | CS |
| 156 | 13.7 | 81.0650887574 | 16.9 | 31.31 | 15.0001 | 56532 | 20.81323242 | CS |
| 260 | 13.7 | 81.0650887574 | 16.9 | 31.31 | 15.0001 | 56532 | 20.81323242 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
